Tag: Shire

Servier buys oncology business from Shire

shire
Shire, the leading global biotechnology company focused on rare diseases announced that it has entered into a definitive agreement with to sell its Oncology business for $2.4 billion.

Shire and NanoMedSyn started a research collaboration

biotechnology
Shire, the global biotechnology leader, and NanoMedSyn, a biotechnology company dedicated to innovation in enzyme replacement therapy, announced that the companies have entered into a preclinical research collaboration.

Shire received EU marketing authorization for its hemophilia drug

shire
Shire announced that the European Commission has granted Marketing Authorization for ADYNOVI, an extended half-life recombinant factor VIII treatment, for use in patients with hemophilia A

Shire received EU marketing authorisation for Natpar

shire
Shire announced that the European Commission (EC) has granted Conditional Marketing Authorisation for Natpar, the first recombinant human protein with the full length 84-amino acid sequence of endogen...

Generium and Shire established a joint venture

generium
Generium, a Russian pharmaceutical company, established a joint venture (SG Biotech) with Shire, an Irish corporation. New partners already control about 70% of the government procurement market of dr...